Delivery, structure, and function of bacterial genotoxins

References

• Guerra L, Cortes-Bratti X, Guidi R, et al. The biology of the cytolethal distending toxins. Toxins (Basel). 2011;3:172–190.
   PubMed Web of Science ®Google Scholar
• Lara-Tejero M, Galán JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science. 2000;290(5490):354–357.
   PubMed Web of Science ®Google Scholar
• Lara-Tejero M, Galán JE. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 2002;10(3):147–152.
   PubMed Web of Science ®Google Scholar
• Scuron MD, Boesze-Battaglia K, Dlakic M, et al. The cytolethal distending toxin contributes to microbial virulence and disease pathogenesis by acting as a tri-perditious toxin. Front Cell Infect Mi. 2016;6. DOI:10.3389/fcimb.2016.00168
   PubMed Web of Science ®Google Scholar
• Song J, Gao X, Galan JE. Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature. 2013;499(7458):350–354.
   PubMed Web of Science ®Google Scholar
• Nougayrède JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851.
   PubMed Web of Science ®Google Scholar
• Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042–1054, e1041.
   PubMed Web of Science ®Google Scholar
• Nesić D, Hsu Y, Stebbins CE. Assembly and function of a bacterial genotoxin. Nature. 2004;429:429–433.
   PubMed Web of Science ®Google Scholar
• Stanaway JD RR, Blacker BF, Goldberg EM, et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the global burden of disease study 2017. Lancet Infect Dis. 2019;19(4):369–381.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci, USA. 2010;107(25):11537–11542.
   PubMed Web of Science ®Google Scholar
• Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog. 1988a;4(2):115–126.
   PubMed Web of Science ®Google Scholar
• Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog. 1988b;4(2):103–113.
   PubMed Web of Science ®Google Scholar
• Lai CK, Chen YA, Lin CJ, et al. Molecular mechanisms and potential clinical applications of campylobacter jejuni cytolethal distending toxin. Front Cell Infect Microbiol. 2016;6:9. DOI:10.3389/fcimb.2016.00009
   PubMed Web of Science ®Google Scholar
• Mortensen NP, Schiellerup P, Boisen N, et al. The role of Campylobacter jejuni cytolethal distending toxin in gastroenteritis: toxin detection, antibody production, and clinical outcome. Apmis. 2011;119:626–634.
   PubMed Web of Science ®Google Scholar
• Tegtmeyer N, Sharafutdinov I, Harrer A, et al. Campylobacter virulence factors and molecular host-pathogen interactions. Curr Top Microbiol Immunol. 2021;431:169–202.
   PubMed Web of Science ®Google Scholar
• Pickett CL, Pesci EC, Cottle DL, et al. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun. 1996;64(6):2070–2078.
   PubMed Web of Science ®Google Scholar
• Fox JG, Rogers AB, Whary MT, et al. Gastroenteritis in NF-κB-deficient mice is produced with wild-type campylobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun. 2004;72(2):1116–1125.
   PubMed Web of Science ®Google Scholar
• Jain D, Prasad KN, Sinha S, et al. Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol. 2008;57(Pt 3):267–272.
   PubMed Web of Science ®Google Scholar
• Purdy D, Buswell CM, Hodgson AE, et al. Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J Med Microbiol. 2000;49(5):473–479.
   PubMed Web of Science ®Google Scholar
• Hinenoya A, Naigita A, Ninomiya K, et al. Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan. Microbiol Immunol. 2009;53(4):206–215.
   PubMed Web of Science ®Google Scholar
• Meza-Segura M, Zaidi MB, Maldonado-Puga S, et al. Cytolethal distending toxin-producing Escherichia coli strains causing severe diarrhoea in young Mexican children. JMM Case Rep. 2017;4(2):e005079.
   PubMedGoogle Scholar
• Scorza FB, Doro F, Rodriguez-Ortega MJ, et al. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli δtolr IHE3034 mutant. Mol Cell Proteomics. 2008;7(3):473–485. DOI:10.1074/mcp.M700295-MCP200
   PubMed Web of Science ®Google Scholar
• Taieb F, Svab D, Watrin C, et al. Cytolethal distending toxin A, B and C subunit proteins are necessary for the genotoxic effect of Escherichia coli CDT-V. Acta Vet Hung. 2015;63(1):1–10.
   PubMed Web of Science ®Google Scholar
• Toth I, Herault F, Beutin L, et al. Production of cytolethal distending toxins by pathogenic Escherichia coli Strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J Clin Microbiol. 2003;41(9):4285–4291.
   PubMed Web of Science ®Google Scholar
• Johnson TJ, Kariyawasam S, Wannemuehler Y, et al. The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol. 2007;189(8):3228–3236.
   PubMed Web of Science ®Google Scholar
• Peres SY, Marches O, Daigle F, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol. 1997;24(5):1095–1107.
   PubMed Web of Science ®Google Scholar
• Svab D, Horvath B, Maroti G, et al. Sequence variability of P2-like prophage genomes carrying the cytolethal distending toxin V operon in Escherichia coli O157. Appl Environ Microbiol. 2013;79(16):4958–4964.
   PubMed Web of Science ®Google Scholar
• Toth I, Nougayrede JP, Dobrindt U, et al. cytolethal distending toxin type i and type iv genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun. 2009;77(1):492–500.
   PubMed Web of Science ®Google Scholar
• de Paula Coelho C, Motta PD, Petrillo M, et al. Homeopathic medicine Cantharis modulates uropathogenic E. coli (UPEC)-induced cystitis in susceptible mice. Cytokine. 2017;92:103–109.
   PubMed Web of Science ®Google Scholar
• Ahmed HJ, Svensson LA, Cope LD, et al. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol. 2001;50(10):860–864.
   PubMed Web of Science ®Google Scholar
• Lewis DA, Stevens MK, Latimer JL, et al. Characterization of Haemophilus ducreyi cdtA, cdtB , and cdtC Mutants in in vitro and in vivo systems. Infect Immun. 2001;69(9):5626–5634.
   PubMed Web of Science ®Google Scholar
• Kaplan AH, Weber DJ, Oddone EZ, et al. Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review. Rev Infect Dis. 1989;11(1):46–63.
   PubMedGoogle Scholar
• Mayer MP, Bueno LC, Hansen EJ, et al. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun. 1999;67(3):1227–1237.
   PubMed Web of Science ®Google Scholar
• Herbert BA, Novince CM, Kirkwood KL. Aggregatibacter actinomycetemcomitans , a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. Mol Oral Microbiol. 2016;31(3):207–227.
   PubMed Web of Science ®Google Scholar
• Ohara M, Miyauchi M, Tsuruda K, et al. Topical application of Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces cell cycle arrest in the rat gingival epithelium in vivo. J Periodontal Res. 2011;46(3):389–395.
   PubMed Web of Science ®Google Scholar
• Akifusa S, Poole S, Lewthwaite J, et al. Recombinant actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun. 2001;69(9):5925–5930.
   PubMed Web of Science ®Google Scholar
• Ando-Suguimoto ES, da Silva MP, Kawamoto D, et al. The cytolethal distending toxin of Aggregatibacter actinomycetemcomitans inhibits macrophage phagocytosis and subverts cytokine production. Cytokine. 2014;66(1):46–53.
   PubMed Web of Science ®Google Scholar
• Belibasakis GN, Johansson A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine. 2012;59:124–130.
   PubMed Web of Science ®Google Scholar
• Belibasakis GN, Johansson A, Wang Y, et al. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine. 2005;30:56–63.
   PubMed Web of Science ®Google Scholar
• Shenker BJ, Boesze-Battaglia K, Scuron MD, et al. The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol. 2016a;18(2):223–243.
   PubMed Web of Science ®Google Scholar
• Shenker BJ, Walker LP, Zekavat A, et al. Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Mol Oral Microbiol. 2016b;31(31):33–42.
   PubMedGoogle Scholar
• Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun. 1994;62(1):244–251.
   PubMed Web of Science ®Google Scholar
• Tóth I, Hérault F, Beutin L, et al. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type iV). J Clin Microbiol. 2003;41(9):4285–4291.
   PubMed Web of Science ®Google Scholar
• Tóth I, Nougayrède JP, Dobrindt U, et al. Cytolethal distending toxin type i and type iv genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun. 2009;77(1):492–500.
   PubMed Web of Science ®Google Scholar
• Wilson BA, Winkler ME, Ho BT. Bacterial pathogenesis: a molecular approach. 4th ed. Washington (DC): ASM Press(Chapter 12); 2019a.
   Google Scholar
• Ueno Y, Ohara M, Kawamoto T, et al. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect Immun. 2006;74(6):3480–3487.
   PubMed Web of Science ®Google Scholar
• Tsuruda K, Matangkasombut O, Ohara M, et al. CdtC-Induced processing of membrane-bound CdtA is a crucial step in aggregatibacter actinomycetemcomitans cytolethal distending toxin holotoxin formation. Infect Immun. 2018;86(3). DOI:10.1128/IAI.00731-17
   PubMed Web of Science ®Google Scholar
• Buddelmeijer N. The molecular mechanism of bacterial lipoprotein modification—how, when and why? FEMS Microbiol Rev. 2015;39(2):246–261.
   PubMed Web of Science ®Google Scholar
• Davies C, Taylor AJ, Elmi A, et al. Sodium taurocholate stimulates campylobacter jejuni outer membrane vesicle production via down-regulation of the maintenance of lipid asymmetry pathway. Front Cell Infect Microbiol. 2019;9:177.
   PubMed Web of Science ®Google Scholar
• Cao L, Volgina A, Huang CM, et al. Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol. 2005;58(5):1303–1321.
   PubMed Web of Science ®Google Scholar
• McSweeney LA, Dreyfus LA. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect Immun. 2005;73(4):2051–2060.
   PubMed Web of Science ®Google Scholar
• Mise K, Akifusa S, Watarai S, et al. Involvement of ganglioside GM3 in G 2 /M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect Immun. 2005;73(8):4846–4852.
   PubMed Web of Science ®Google Scholar
• Guerra L, Teter K, Lilley BN, et al. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol. 2005;7(7):921–934.
   PubMed Web of Science ®Google Scholar
• Eshraghi A, Dixon SD, Tamilselvam B, et al. Cytolethal distending toxins require components of the ER-associated degradation pathway for host cell entry. PLoS Pathog. 2014;10(7):e1004295.
   PubMed Web of Science ®Google Scholar
• Nishikubo S, Ohara M, Ueno Y, et al. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem. 2003;278:50671–50681.
   PubMed Web of Science ®Google Scholar
• Eshraghi A, Maldonado-Arocho FJ, Gargi A, et al. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J Biol Chem. 2010;285:18199–18207.
   PubMed Web of Science ®Google Scholar
• Frisan T. Bacterial genotoxins: the long journey to the nucleus of mammalian cells. Biochim Biophys Acta. 2016;1858(3):567–575.
   PubMed Web of Science ®Google Scholar
• Hu X, Nesic D, Stebbins CE. Comparative structure-function analysis of cytolethal distending toxins. Proteins. 2006;62(2):421–434.
   PubMed Web of Science ®Google Scholar
• Boesze-Battaglia K, Besack D, McKay T, et al. Cholesterol-Rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell Microbiol. 2006;8(5):823–836.
   PubMed Web of Science ®Google Scholar
• Lin CD, Lai CK, Lin YH, et al. Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells. Infect Immun. 2011;79(9):3563–3575.
   PubMed Web of Science ®Google Scholar
• Carette JE, Guimaraes CP, Wuethrich I, et al. Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol. 2011;29(6):542–546. DOI:10.1038/nbt.1857
   PubMed Web of Science ®Google Scholar
• Boesze-Battaglia K, Brown A, Walker L, et al. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J Biol Chem. 2009;284:10650–10658.
   PubMed Web of Science ®Google Scholar
• Damek-Poprawa M, Jang JY, Volgina A, et al. Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect Immun. 2012;80(8):2761–2770.
   PubMed Web of Science ®Google Scholar
• Robb Huhn G 3rd, Torres-Mangual N, Clore J, et al. Endocytosis of the CdtA subunit from the Haemophilus ducreyi cytolethal distending toxin. Cell Microbiol. 2021;23(11):e13380.
   PubMed Web of Science ®Google Scholar
• Gargi A, Tamilselvam B, Powers B, et al. Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J Biol Chem. 2013;288(11):7492–7505.
   PubMed Web of Science ®Google Scholar
• Chang SJ, Jin SC, Jiao X, et al. Unique features in the intracellular transport of typhoid toxin revealed by a genome-wide screen. PLoS Pathog. 2019;15(4):e1007704.
   PubMed Web of Science ®Google Scholar
• Guerra L, Nemec KN, Massey S, et al. A novel mode of translocation for cytolethal distending toxin. Biochim Biophys Acta. 2009;1793(3):489–495.
   PubMed Web of Science ®Google Scholar
• McSweeney LA, Dreyfus LA. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol. 2004;6:447–458.
   PubMed Web of Science ®Google Scholar
• Spanò S, Ugalde JE, Galán JE. Delivery of a Salmonella Typhi exotoxin from a host intracellular compartment. Cell Host Microbe. 2008;3(1):30–38.
   PubMed Web of Science ®Google Scholar
• Lee S, Yang YA, Milano SK, et al. Salmonella typhoid toxin PltB subunit and its non-typhoidal salmonella ortholog confer differential host adaptation and virulence. Cell Host Microbe. 2020;27(6):937–949. DOI:10.1016/j.chom.2020.04.005
   PubMed Web of Science ®Google Scholar
• Nguyen T, Lee S, Yang YA, et al. The role of 9-O-acetylated glycan receptor moieties in the typhoid toxin binding and intoxication. PLoS Pathog. 2020;16(2):e1008336. DOI:10.1371/journal.ppat.1008336
   PubMed Web of Science ®Google Scholar
• Yang YA, Lee S, Zhao J, et al. In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor. Nat Microbiol. 2018;3(2):155–163.
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Gaffey MF, Crump JA, et al. Typhoid fever: way forward. Am J Trop Med Hyg. 2018;99(3_Suppl):89–96.
   PubMed Web of Science ®Google Scholar
• Ahn C, Yang Y-A, Neupane DP, et al. Mechanisms of typhoid toxin neutralization by antibodies targeting glycan receptor binding and nuclease subunits. iScience. 2021;24:102454.
   PubMed Web of Science ®Google Scholar
• Haghjoo E, Galán JE. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci, USA. 2004;101(13):4614–4619.
   PubMed Web of Science ®Google Scholar
• Fowler CC, Stack G, Jiao X, et al. Alternate subunit assembly diversifies the function of a bacterial toxin. Nat Commun. 2019;10(1):3684.
   PubMedGoogle Scholar
• Geiger T, Lara-Tejero M, and Xiong Y, et al. Mechanisms of substrate recognition by a typhoid toxin secretion-associated muramidase. Elife. 2020;9:e53473. doi:10.7554/eLife.53473.
   Web of Science ®Google Scholar
• Chang SJ, Song J, Galan JE. Receptor-mediated sorting of typhoid toxin during its export from salmonella typhi-infected cells. Cell Host Microbe. 2016;20(5):682–689.
   PubMed Web of Science ®Google Scholar
• Petersen E, Miller SI. Toxin glycan binding: lectin keys unlocking host and tissue specificity. Cell Host Microbe. 2020;27(6):851–853.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Richards AF, Neupane DP, et al. The structural basis of Salmonella A(2)B(5) toxin neutralization by antibodies targeting the glycan-receptor binding subunits. Cell Rep. 2021;36(10):109654. DOI:10.1016/j.celrep.2021.109654
   PubMed Web of Science ®Google Scholar
• Lee S, Inzerillo S, Lee GY, et al. Glycan-Mediated molecular interactions in bacterial pathogenesis. Trends Microbiol. 2021;30(3):254–267.
   PubMed Web of Science ®Google Scholar
• Putze J, Hennequin C, Nougayrède JP, et al. Genetic structure and distribution of the colibactin genomic island among members of the family enterobacteriaceae. Infect Immun. 2009;77(11):4696–4703. DOI:10.1128/IAI.00522-09
   PubMed Web of Science ®Google Scholar
• Colis LC, Woo CM, Hegan DC, et al. The cytotoxicity of (−)-lomaiviticin a arises from induction of double-strand breaks in DNA. Nat Chem. 2014;6(6):504–510.
   PubMed Web of Science ®Google Scholar
• Woo CM, Li Z, Paulson EK, et al. Structural basis for DNA cleavage by the potent antiproliferative agent (–)-lomaiviticin a. Proc Natl Acad Sci, USA. 2016;113(11):2851–2856.
   PubMed Web of Science ®Google Scholar
• Faïs T, Delmas J, Barnich N, et al. Colibactin: more than a new bacterial toxin. Toxins (Basel). 2018;10(4):151.
   PubMed Web of Science ®Google Scholar
• Lan Y, Zhou M, Jian Z, et al. Prevalence of pks gene cluster and characteristics of Klebsiella pneumoniae -induced bloodstream infections. J Clin Lab Anal. 2019;33(4):e22838.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Gibold L, Robin F, et al. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol. 2012;424(3–4):203–214.
   PubMed Web of Science ®Google Scholar
• Dubois D, Baron O, Cougnoux A, et al. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem. 2011;286(41):35562–35570.
   PubMed Web of Science ®Google Scholar
• Bian X, Fu J, Plaza A, et al. In vivo evidence for a prodrug activation mechanism during colibactin maturation. Chembiochem. 2013;14:1194–1197.
   PubMed Web of Science ®Google Scholar
• Brotherton CA, Balskus EP. A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. J Am Chem Soc. 2013;135(9):3359–3362.
   PubMed Web of Science ®Google Scholar
• Wernke KM, Xue M, Tirla A, et al. Structure and bioactivity of colibactin. Bioorg Med Chem Lett. 2020;30(15):127280.
   PubMed Web of Science ®Google Scholar
• Healy AR, Nikolayevskiy H, Patel JR, et al. A mechanistic model for colibactin-induced genotoxicity. J Am Chem Soc. 2016;138(48):15563–15570.
   PubMed Web of Science ®Google Scholar
• Trautman EP, Healy AR, Shine EE, et al. Domain-targeted metabolomics delineates the heterocycle assembly steps of colibactin biosynthesis. J Am Chem Soc. 2017;139(11):4195–4201.
   PubMed Web of Science ®Google Scholar
• Healy AR, Wernke KM, Kim CS, et al. Synthesis and reactivity of precolibactin 886. Nat Chem. 2019;11(10):890–898.
   PubMed Web of Science ®Google Scholar
• Taieb F, Petit C, Nougayrede JP, et al. The enterobacterial genotoxins: cytolethal distending toxin and colibactin. EcoSal Plus. 2016;7(1). DOI:10.1128/ecosalplus.ESP-0008-2016
   PubMedGoogle Scholar
• Wilson MR, Jiang YD, Villalta PW, et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019b;363:709±. DOI:10.1126/science.aar7785
   Web of Science ®Google Scholar
• Shine EE, Xue M, Patel JR, et al. Model colibactins exhibit human cell genotoxicity in the absence of host bacteria. ACS Chem Biol. 2018;13(12):3286–3293.
   PubMed Web of Science ®Google Scholar
• Raisch J, Buc E, Bonnet M, et al. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol. 2014;20(21):6560–6572. DOI:10.3748/wjg.v20.i21.6560
   PubMed Web of Science ®Google Scholar
• Silpe JE, Wong JWH, Owen SV, et al. The bacterial toxin colibactin triggers prophage induction. Nature. 2022;603(7900):315–320.
   PubMedGoogle Scholar
• Dlakic M. Functionally unrelated signalling proteins contain a fold similar to Mg2±dependent endonucleases. Trends Biochem Sci. 2000;25(6):272–273.
   PubMed Web of Science ®Google Scholar
• Dlakic M. Is CdtB a nuclease or a phosphatase? Science. 2001;291(5504):547.
   PubMedGoogle Scholar
• Hontz JS, Villar-Lecumberri MT, Potter BM, et al. Differences in crystal and solution structures of the cytolethal distending toxin B subunit: relevance to nuclear translocation and functional activation. J Biol Chem. 2006;281(35):25365–25372.
   PubMed Web of Science ®Google Scholar
• Lahm A, Suck D. Dnase I-induced DNA conformation. 2 a structure of a DNase I-octamer complex. J Mol Biol. 1991;222(3):645–667.
   PubMed Web of Science ®Google Scholar
• Yamada T, Komoto J, Saiki K, et al. Variation of loop sequence alters stability of cytolethal distending toxin (CDT): crystal structure of CDT from Actinobacillus actinomycetemcomitans. Protein Sci. 2006;15(2):362–372.
   PubMed Web of Science ®Google Scholar
• Bezine E, Malaise Y, Loeuillet A, et al. Cell resistance to the cytolethal distending toxin involves an association of DNA repair mechanisms. Sci Rep. 2016;6(1):36022.
   PubMedGoogle Scholar
• Blazkova H, Krejcikova K, Moudry P, et al. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J Cell Mol Med. 2010;14(1–2):357–367.
   PubMed Web of Science ®Google Scholar
• Fahrer J, Huelsenbeck J, Jaurich H, et al. Cytolethal distending toxin (CDT) is a radiomimetic agent and induces, persistent levels of DNA.Double-strand breaks in human fibroblasts. DNA Repair (Amst). 2014;18:31–43.
   PubMed Web of Science ®Google Scholar
• Fedor Y, Vignard J, Nicolau-Travers ML, et al. From single-strand breaks to double-strand breaks during S-phase: a new mode of action of the Escherichia coli cytolethal distending toxin. Cell Microbiol. 2013;15(1):1–15.
   PubMed Web of Science ®Google Scholar
• Li L, Sharipo A, Chaves-Olarte E, et al. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol. 2002;4(2):87–99.
   PubMed Web of Science ®Google Scholar
• Shenker BJ, Dlakic M, Walker LP, et al. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J Immunol. 2007;178(8):5099–5108.
   PubMed Web of Science ®Google Scholar
• Elwell CA, Dreyfus LA. Dnase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol. 2000;37(4):952–963.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Ulmer JS, Herzka A, et al. Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci. 1998;7(3):628–636.
   PubMed Web of Science ®Google Scholar
• Hassane DC, Lee RB, Mendenhall MD, et al. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun. 2001;69(9):5752–5759.
   PubMed Web of Science ®Google Scholar
• Hassane DC, Lee RB, Pickett CL. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect Immun. 2003;71(1):541–545.
   PubMed Web of Science ®Google Scholar
• Elwell C, Chao K, Patel K, et al. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun. 2001;69(5):3418–3422.
   PubMed Web of Science ®Google Scholar
• Frisan T, Nagy N, Chioureas D, et al. A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis. Int J Cancer. 2019;144(1):98–109.
   PubMed Web of Science ®Google Scholar
• Seiwert N, Neitzel C, Stroh S, et al. AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells. Cell Death Dis. 2017;8(8):e3019.
   PubMedGoogle Scholar
• Xue M, Shine E, Wang W, et al. Characterization of natural colibactin–nucleobase adducts by tandem mass spectrometry and isotopic labeling. support for DNA alkylation by cyclopropane ring opening. Biochemistry. 2018;57(45):6391–6394.
   PubMed Web of Science ®Google Scholar
• Bossuet-Greif N, Vignard J, Taieb F, et al. The colibactin genotoxin generates DNA interstrand cross-links in infected cells. mBio. 2018;9(2). DOI:10.1128/mBio.02393-17
   PubMed Web of Science ®Google Scholar
• Clauson C, Schärer OD, Niedernhofer L. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Biol. 2013;5(10):a012732.
   PubMed Web of Science ®Google Scholar
• Xue M, Wernke KM, Herzon SB. Depurination of colibactin-derived interstrand cross-links. Biochemistry. 2020;59:892–900.
   PubMed Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580(7802):269–273. DOI:10.1038/s41586-020-2080-8
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–123. DOI:10.1126/science.1224820
   PubMed Web of Science ®Google Scholar
• Nougayrède JP, Chagneau CV, Motta JP, et al. A toxic friend: genotoxic and mutagenic activity of the probiotic strain Escherichia coli Nissle 1917. mSphere. 2021;6:e0062421.
   PubMed Web of Science ®Google Scholar
• Olier M, Marcq I, Salvador-Cartier C, et al. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes. 2012;3(6):501–509. DOI:10.4161/gmic.21737
   PubMed Web of Science ®Google Scholar
• Tronnet S, Floch P, Lucarelli L, et al. The genotoxin colibactin shapes gut microbiota in mice. mSphere. 2020;5(4). DOI:10.1128/mSphere.00589-20
   PubMed Web of Science ®Google Scholar
• Nipič D, Podlesek Z, Budič M, et al. Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J Infect Dis. 2013;208(10):1545–1552.
   PubMed Web of Science ®Google Scholar
• Lloyd AL, Rasko DA, Mobley HL. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol. 2007;189(9):3532–3546.
   PubMed Web of Science ®Google Scholar
• Roche-Lima A, Carrasquillo-Carrión K, Gómez-Moreno R, et al. The presence of genotoxic and/or pro-inflammatory bacterial genes in gut metagenomic databases and their possible link with inflammatory bowel diseases. Front Genet. 2018;9:116.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nakano M, Terai A, et al. The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J Urol. 2001;165(4):1347–1351.
   PubMed Web of Science ®Google Scholar
• Rihtar E, Zgur Bertok D, Podlesek Z. The uropathogenic specific protein gene usp from Escherichia coli and salmonella bongori is a novel member of the TyrR and H-NS regulons. Microorganisms. 2020;8(3):8.
   Web of Science ®Google Scholar
• Bergounioux J, Elisee R, Prunier AL, et al. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium’s epithelial niche. Cell Host Microbe. 2012;11(3):240–252.
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. Mbio. 2013;4:e00152–00113. DOI:10.1128/mBio.00152-13.
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Short AJ, Donnenberg MS, et al. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One. 2009;4(5):e5517.
   PubMed Web of Science ®Google Scholar